Indication
Acute on Chronic
2 clinical trials
2 products
Clinical trial
Mesenchymal Stem Cells-Derived Extracellular Vesicles (MSC-EV) in Acute-on-Chronic Liver Failure After Liver Transplantationa：a Prospective, Randomized, Controlled Clinical StudyStatus: Withdrawn, Estimated PCD: 2024-09-30
Product
MSC-EVClinical trial
The Efficacy and Safety of Rifaximin In The Treatment of HBV Associated Acute-on-Chronic Liver Failure Patients With Mild to Moderate Hepatic EncephalopathyStatus: Recruiting, Estimated PCD: 2025-07-31
Product
Rifaximin